• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OREGON MANUFACTURING PLANT NATURALYTE 3301 3K 3.0CA 1MG GAL; DIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OREGON MANUFACTURING PLANT NATURALYTE 3301 3K 3.0CA 1MG GAL; DIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER) Back to Search Results
Model Number 08-3301-2
Medical Device Problem Code Chemical Problem (2893)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 11/04/2020
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.
 
Event or Problem Description
A user facility biomedical technician (biomed) reported to technical support a low conductivity alarm caused by the naturalyte liquid concentrate.Upon follow up, the customer said that during treatment, the conductivity was at 13.3 and tcd 13.8.The patient was switched to another lot mid-treatment without any ill effects or adverse events.Per the biomed, there has not been any recent service to the machine that would effect conductivity and that they use bibag 400rx12, lot number unknown.The biomed reported that there are 4 cases affected.
 
Additional Manufacturer Narrative
Plant investigation: a product history review was performed.A review of the complaint management system identified 5 additional complaints related to conductivity issues with the reported lot.A review of the product inventory records for lot no.20nxac006 indicated that 2190 cases of finished product were manufactured for distribution with no noted nonconformances.After reviewing the finished product release summary, it was determined that 20nxac006 met release specifications.As of 11/20/2020 no samples were returned.Samples are not needed to confirm the allegation.A sample retain was tested and found to be within specifications.Through other complaint allegations of the same issue for lots 20lxac056, 20lxac058, and 20lxac076, there were companion samples available for testing which were tested at both the oregon and irving laboratories and results were found to be conflicting.Due to the conflicting results found between the laboratories, the oregon test methods were reviewed and a deficiency was found in the test method pertaining to the sodium and potassium analyte tests.Because of the deficiency found in the test method, it was determined that lot 20nxac006 did not meet release specifications and the allegation conductivity low was confirmed.In conclusion, 20nxac006 release testing was found to be compromised due to the deficient test method.A non-conformance was opened for allegations of conductivity issues and escalated to a corrective action preventative action (capa).Based on the investigation performed, cause was traced to manufacturing.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NATURALYTE 3301 3K 3.0CA 1MG GAL
Common Device Name
DIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
Manufacturer (Section D)
OREGON MANUFACTURING PLANT
director, quality systems
750 n lallendorf road
oregon OH 43616
MDR Report Key10906096
Report Number3005162618-2020-00010
Device Sequence Number16951039
Product Code KPO
UDI-Device Identifier00840861101757
UDI-Public00840861101757
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
K192017
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,user f
Initial Reporter Occupation Biomedical Engineer
Type of Report Initial,Followup
Report Date (Section B) 12/08/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/31/2022
Device Model Number08-3301-2
Device Catalogue Number08-3301-2
Device Lot Number20NXAC006
Was Device Available for Evaluation? No
Device AgeMO
Initial Date Received by Manufacturer 11/06/2020
Supplement Date Received by Manufacturer12/02/2020
Initial Report FDA Received Date11/25/2020
Supplement Report FDA Received Date12/08/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-